Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort

BJU International

Volumn 112, Issue 5, 2013, Pages 666-673

  Goh, Chee L ^a   Saunders, Edward J ^a   Leongamornlert, Daniel A ^a   Tymrakiewicz, Malgorzata ^a   Thomas, Karen ^b   Selvadurai, Elizabeth D ^b   Woode Amissah, Ruth ^b   Dadaev, Tokhir ^a   Mahmud, Nadiya ^a   Castro, Elena ^a   Olmos, David ^c   Guy, Michelle ^a   Govindasami, Koveela ^a   O'Brien, Lynne T ^a   Hall, Amanda L ^a   Wilkinson, Rosemary A ^a   Sawyer, Emma J ^a   Al Olama, Ali Amin ^d   Easton, Douglas F ^d,e   Kote Jarai, Zsofia ^a   Parker, Chris C ^b   Eeles, Rosalind A ^a,b   more..

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c Centro Nacional de Investigations Oncológicas   (Spain)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

active surveillance; family history; genetic risk profiles; prostate cancer

Indexed keywords

ACTIVE SURVEILLANCE; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; DISEASE SURVEILLANCE; FAMILY HISTORY; FIRST DEGREE RELATIVE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REPEAT PROCEDURE; RETROSPECTIVE STUDY; SCORING SYSTEM; SECOND DEGREE RELATIVE; SINGLE NUCLEOTIDE POLYMORPHISM; TIME TO TREATMENT; UNITED KINGDOM;

ACTIVE SURVEILLANCE; FAMILY HISTORY; GENETIC RISK PROFILES; PROSTATE CANCER;

AGED; FAMILY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENTINEL SURVEILLANCE;

EID: 84882279408     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11648.x     Document Type: Article

References (34)

1. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78-85
2. Goh CL, Schumacher FR, Easton D, et al. Genetic Variants Associated With Predisposition to Prostate Cancer and Potential Clinical Implications. J Intern Med 2012; 271: 353-365
3. Karlsson R, Aly M, Clements M, et al. A Population-based Assessment of Germline HOXB13 G84E Mutation and Prostate Cancer Risk. Eur Urol 2012; [Epub ahead of print]. doi: 10.1016/j.eururo.2012.07.027
4. Evans S, Metcalfe C, Ibrahim F, Persad R, Ben-Shlomo Y,. Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis. Int J Cancer 2008; 123: 430-435
5. Brandt A, Sundquist J, Hemminki K,. Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer. Ann Oncol 2012; 23: 251-256
6. Lawrentschuk N, Klotz L,. Active surveillance for low-risk prostate cancer: an update. Nat Rev Urol 2011; 8: 312-320
7. Ahmed HU, Akin O, Coleman JA, et al. Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer. BJU Int 2012; 109: 1636-1647
8. Ng MK, Van As N, Thomas K, et al. Prostate-specific antigen (PSA) kinetics in untreated, localized prostate cancer: PSA velocity vs PSA doubling time. BJU Int 2009; 103: 872-876
9. Ross AE, Loeb S, Landis P, et al. Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program. J Clin Oncol 2010; 28: 2810-2816
10. Gabriel S, Ziaugra L, Tabbaa D,. SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet 2009; 60: 2.12.1-2.12.18
11. Kote-Jarai Z, Olama AA, Giles GG, et al. Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet 2011; 43: 785-791
12. Gudmundsson J, Sulem P, Rafnar T, et al. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 2008; 40: 281-283
13. Eeles RA, Kote-Jarai Z, Al Olama AA, et al. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet 2009; 41: 1116-1121
14. Eeles RA, Kote-Jarai Z, Giles GG, et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 2008; 40: 316-321
15. Gudmundsson J, Sulem P, Gudbjartsson DF, et al. Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat Genet 2009; 41: 1122-1126
16. Thomas G, Jacobs KB, Yeager M, et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008; 40: 310-315
17. Amundadottir LT, Sulem P, Gudmundsson J, et al. A common variant associated with prostate cancer in European and African populations. Nat Genet 2006; 38: 652-658
18. Yeager M, Orr N, Hayes RB, et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007; 39: 645-649
19. Gudmundsson J, Sulem P, Manolescu A, et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 2007; 39: 631-637
20. Al Olama AA, Kote-Jarai Z, Giles GG, et al. Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet 2009; 41: 1058-1060
21. Duggan D, Zheng SL, Knowlton M, et al. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst 2007; 99: 1836-1844
22. Gudmundsson J, Sulem P, Steinthorsdottir V, et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 2007; 39: 977-983
23. Sun J, Zheng SL, Wiklund F, et al. Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat Genet 2008; 40: 1153-1155
24. Schleinitz D, Distefano JK, Kovacs P,. Targeted SNP genotyping using the TaqMan(R) assay. Methods Mol Biol 2011; 700: 77-87
25. Pereira TV, Patsopoulos NA, Salanti G, Ioannidis JP,. Discovery properties of genome-wide association signals from cumulatively combined data sets. Am J Epidemiol 2009; 170: 1197-1206
26. Cussenot O, Azzouzi AR, Bantsimba-Malanda G, et al. Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer. Clin Cancer Res 2008; 14: 5635-5639
27. Gudmundsson J, Besenbacher S, Sulem P, et al. Genetic correction of PSA values using sequence variants associated with PSA levels. Sci Transl Med 2010; 2: 62ra92
28. San Francisco IF, Werner L, Regan MM, Garnick MB, Bubley G, DeWolf WC,. Risk stratification and validation of prostate specific antigen density as independent predictor of progression in men with low risk prostate cancer during active surveillance. J Urol 2011; 185: 471-476
29. McGuire BB, Helfand BT, Kundu S, et al. Association of prostate cancer risk alleles with unfavourable pathological characteristics in potential candidates for active surveillance. BJU Int 2012; 110: 338-343
30. Castro E, Goh CL, Olmos D, et al. Correlation of germline BRCA2 mutations with aggressive prostate cancer and outcome. J Clin Oncol 2011; 29 (Suppl.); abstract 1517
31. National Institute of Health. ELLIPSE (Elucidating Loci Involved in Prostate Cancer Susceptibility). 2010. [updated December 2, 2010; cited 2011 July 1]; Available at: http://epi.grants.cancer.gov/pgwas/personnel. html#ellipse. Accessed September 2012
32. Davies NJ, Batehup L, Thomas R,. The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer 2011; 105 (Suppl. 1): S52-73
33. COGS. Collaborative Oncological Gene-environment Study. 2009. [cited 2011 July 1]; Available at: http://www.cogseu.org/. Accessed September 2012
34. Waters KM, Le Marchand L, Kolonel LN, et al. Generalizability of associations from prostate cancer genome-wide association studies in multiple populations. Cancer Epidemiol Biomarkers Prev 2009; 18: 1285-1289